吡喹酮可以作为肝星状细胞激活的抑制剂。
The praziquantel can be used as an inhibitor for the activation of the hepatic stellate cells.
本发明提供了吡喹酮在制备肝星状细胞激活抑制剂中的应用。
The invention provides an application of praziquantel in preparing a hepatic stellate cell activator-inhibitor.
本综述以肝星状细胞激活与增殖相关信号转导通路为中心，探讨其在肝纤维化发病作用方面的作用机制。
This paper briefly reviews the hepatic stellate cells (HSC) activation and proliferation-related signal transduction pathway and explores the role in the pathogenesis of liver fibrosis.
肝星状细胞的激活、表型改变并分泌大量的细胞外基质是肝纤维化发生的中心环节。
The activation of hepatic stellate cell phenotype change and secretion of extracellular matrix of liver fibrosis is the central link.
目的：在大鼠小肝移植模型的基础上，检测大鼠小肝移植中肝星状细胞的激活在供肝损伤中所起的作用。
AIM: To investigate the role of the activation of hepatic stellate cells in small-for-size graft injury in a rat liver transplantation model.
控制肝星状细胞的激活和增殖并逆肝纤维化的进程是抗肝纤维化研究的重点之一。
The manipulation of the activation and proliferation of hepatic stellate cells and the process of liver fibrosis inversion are the key in anti-liver-fibrosis researches.
目的：在精密肝切片中利用乙醛激活肝星状细胞，建立一种星状细胞激活的体外模型，为研究和筛选阻抑肝纤维化发生的药物奠定基础。
AIM: To activate hepatic stellate cells (HSC) in vitro in precision-cut liver slices (PCLS) stimulated by acetaldehyde for studying and screening anti-fibrotic drugs.
目的：在精密肝切片中利用乙醛激活肝星状细胞，建立一种星状细胞激活的体外模型，为研究和筛选阻抑肝纤维化发生的药物奠定基础。
AIM: To activate hepatic stellate cells (HSC) in vitro in precision-cut liver slices (PCLS) stimulated by acetaldehyde for studying and screening anti-fibrotic drugs.
应用推荐